Hepatitis C drug tested in chimps
Linkedin

Hepatitis C drug tested in chimps

San Antonio : TX : USA | Dec 03, 2009 at 2:44 PM PST
Source: Canadian Broadcasting Corporation
XX XX
Views: Pending
 
An experimental drug to treat hepatitis C has worked in chimpanzees, a study in the journal Science Express reports. Unlike other antiviral drugs that attack the virus, the experimental drug targets a small RNA molecule in the liver that hepatitis C needs to replicate, researchers reported in this... FULL ARTICLE AT Canadian Broadcasting Corporation
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

News Stories

 
  • Experimental hepatitis C drug shows promise

    Sify News
    An experimental drug for hepatitis B has been found extremely effective in the trials conducted over chimpanzees, say researchers. The medication, dubbed SPC3649, has been found to inhibit the virus in chimpanzees and researchers hope it would help...
  • Hepatitis C drug shows promise in S.A. study

    The San Antonio Express-News
    A Danish drug tested in San Antonio chimpanzees is showing promise as a new gene-based therapy that fights hepatitis C and potentially other diseases. The drug, developed by biopharmaceutical firm Santaris Pharma A/S, doesn't directly fight the virus,...
  • Experimental drug is combating hepatitis C in chimps, researchers say

    Los Angeles Times
    The new agent is a so-called antisense drug that binds to RNA required by the virus for replication, preventing the virus from proliferating in the liver. Preliminary tests suggest that the drug, called SPC3649, has no toxic side effects, does not...
  • Hepatitis C drug fights virus in new way

    Reuters
    A drug that targets hepatitis C in an entirely new way was highly effective at suppressing the virus in chimpanzees and kept working for several weeks after the treatment stopped, U.S. researchers said on Thursday. The hope is that the drug -- made...

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.